Soluble fas levels in patients with systemic sclerosis

Archives of Dermatological Research

Volumn 292, Issue 10, 2000, Pages 522-523

  Bianchi, T ^a   Bardazzi, F ^a   Patrizi, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apoptosis; Serum soluble Fas; Systemic sclerosis

Indexed keywords

FAS ANTIBODY;

APOPTOSIS; ARTICLE; DERMATOMYOSITIS; HUMAN; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIGENS, CD95; FEMALE; HUMANS; MALE; SCLERODERMA, SYSTEMIC;

EID: 0034508496     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030000170     Document Type: Article

References (5)

1. Systemic sclerosis: An autoantibody mosaic
2. Fas-FasL interactions: A common pathogenetic mechanism in organ-specific autoimmunity
3. Soluble Fas and soluble Fas ligand in rheumatic diseases
4. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus
5. Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis